HK2 and Hepatic fibrosis: In the process of liver fibrosis, hexokinase-2 (HK2) inhibits the transcriptional activation of fibrosis-suppressing genes by promoting lactylation at histone H3K18 sites rather than acetylation, which reveals the competitive substitution mechanism of lactylation at acetylation modification sites [69,70].